Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

UTI Mutual Fund : UTI Dividend Yield Fund declares tax free dividend of 5%

06/14/2013 | 09:18am US/Eastern

PRESS RELEASE

UTI Dividend Yield Fund declares tax-free dividend of 5%
UTI Dividend Yield Fund declares tax-free dividend of 5% (Re.0.50 per unit on face value of Rs.10) under dividend option-existing plan. Pursuant to the payment of dividend, the NAV of the dividend option-existing plan of the scheme would fall to the extent of payout.
The record date for the dividend is June 19, 2013.
All unit holders registered under the dividend option-existing plan of UTI Dividend Yield Fund as on the record date will be eligible for this dividend. Also investors who join the dividend option-existing plan of the scheme on or before the cut off time of the record date will be eligible for the dividend.
The NAV of UTI Dividend Yield Fund on June 13, 2013 under dividend option-existing plan was Rs.12.9103.
UTI-Dividend Yield Fund is an open-ended equity oriented scheme. The investment objective of the scheme is to provide medium to long-term capital gains and / or dividend distribution by investing predominantly in equity and equity related instruments, which offer high dividend yield. Dividend Yield may be considered as high if it is greater than the dividend yield of the Nifty last released/ published by NSE.
Ms Swati Kulkarni is the fund manager of the scheme.
About UTI Mutual Fund
UTI Mutual Fund is a SEBI registered mutual fund whose Sponsors are State Bank of
India, Punjab National Bank, Bank of Baroda and Life Insurance Corporation of India.
UTI Mutual Fund is one of the largest mutual funds in India with investor accounts of
9.73 million under its 91 domestic schemes / plans as on May 31, 2013.

Sponsors: State Bank of India, Punjab National Bank, Bank of Baroda, Life Insurance Corporation of India

Corporate Office: UTI Tower, 'Gn' Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051. Tel: 6678 6666

Website:www.utimf.com

PRESS RELEASE

Mumbai
June 14, 2013

Registered Office: UTI Tower, 'Gn' Block, Bandra - Kurla Complex, Bandra (E), Mumbai
- 400 051. Phone : 022-66786666. For more information please contact the nearest UTI Financial Centre or your AMFI/NISM certified UTI Mutual Fund independent Financial Advisor (IFA) for a copy of Statement of Additional Information, Scheme Information Document and Key Information Memorandum cum Application Form. Mutual Fund Investments are subject to market risks, read all scheme related
documents carefully

Sponsors: State Bank of India, Punjab National Bank, Bank of Baroda, Life Insurance Corporation of India

Corporate Office: UTI Tower, 'Gn' Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051. Tel: 6678 6666

Website:www.utimf.com

distributed by
React to this article
Latest news
Date Title
05:56p MEADOWBROOK INSURANCE : LendingTree Set to Join the S&P SmallCap 600
05:56p GREENBRIER : Admiral Thomas B. Fargo elected to Greenbrier Board of Directors
05:56pDJContainer Store's Loss Widens Sharply on Higher Spending and Stronger Dollar
05:55p TOYOTA MOTOR : Trio of Murals Immortalize Special Olympics Athletes’ Journeys into Los Angeles History
05:55pDJHighbridge Hires Two Fund Managers From ICG
05:53pDJP&G Settles Suit on Puffed-Up Packaging
05:52p New Greek minister's note to self - 'No triumphalism'
05:51p ECOFIN ECONOMIC AND FINANCIAL AFFAIRS COUNCIL : Remarks by President Donald Tusk on the agreed outcome of the Euro Summit of 7 July 2015 on Greece
05:51p ROVI : Announces Q2 2015 Earnings Results and Conference Call Scheduled for July 30'2015
05:51p STANTEC : Helen Platis joins Stantec as Vice President of Client Development
Latest news
Advertisement
Hot News 
JAYWING : Loss Widens On Operating Costs As It Shakes Up Management
IDOX : Acquisition of Cloud Amber for £5m
Eagle Eye Expects "Material Revenue" From New Sainsbury's Contract
Horizon Pharma goes hostile with $3 billion offer for Depomed
DEXIA : Appointment to the Board of Directors
Most Read News
02:01p JOHNSON & JOHNSON : SIMPONI® Receives European Commission Approval for Treatment of Non-Radiographic Axial Spondyloarthritis
07/06 Samsung Electronics profit guidance suggests costly S6 miss
07/06 CREDIT SUISSE : says has around 27 billion Swiss francs of recapitalisation resources
07/06 Boeing says loss of Ex-Im Bank would be competitive disadvantage
07/06 Aetna CEO addresses antitrust concerns over Humana deal
Most recommended articles
05:55pDJHighbridge Hires Two Fund Managers From ICG
05:53pDJP&G Settles Suit on Puffed-Up Packaging
05:52p New Greek minister's note to self - 'No triumphalism'
05:49p Euro summit statement
05:46p U.S. crude slump cools, market awaits inventory data